Production (Stage)
EGF Theramed Health Corp.
EVAHF
$0.026
-$0.021-44.68%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.26% | -17.72% | -37.55% | -35.36% | -33.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.02% | -16.59% | -36.63% | -34.48% | -33.93% |
| Operating Income | 5.02% | 16.59% | 36.63% | 34.48% | 33.93% |
| Income Before Tax | -28.40% | -27.70% | 37.41% | 54.86% | 66.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.66% | -28.94% | 37.41% | 54.86% | 66.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 58.54% | 175.93% | 31.53% | 29.03% | -30.21% |
| Net Income | -27.66% | -22.36% | 39.93% | 57.61% | 67.81% |
| EBIT | 5.02% | 16.59% | 36.63% | 34.48% | 33.93% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -19.25% | -12.89% | 44.76% | 64.24% | 89.53% |
| Normalized Basic EPS | -10.94% | -2.92% | 50.29% | 68.21% | 72.29% |
| EPS Diluted | -19.25% | -12.89% | 44.76% | 64.24% | 89.53% |
| Normalized Diluted EPS | -10.94% | -2.92% | 50.29% | 68.21% | 72.29% |
| Average Basic Shares Outstanding | 5.03% | 6.70% | 8.44% | 12.21% | 38.91% |
| Average Diluted Shares Outstanding | 5.03% | 6.70% | 8.44% | 12.21% | 38.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |